Novella (Accelerator)

Company Description: Bio-tech start-up Novella, established in 2022, cultures next-generation plant-sourced ingredients featuring powerful micronutrients by leveraging proprietary growing technology. The Novella-developed technology optimizes botanical component growth to obtain active substances. Novella will produce these precise bioactives in plant-cell bioreactors that increase ingredients’ nutritional, marketing, and economic value. In the process, Novella lightens the ecological footprint – narrowing the harvest of an entire field for its plant essence into a single bioreactor and eliminating the need for vast cultivated lands and intensive industrial production. This climate-resilient approach diminishes reliance on finite resources, overcomes supply chain disruptions, and expands plant lifecycles. Another huge advantage, Novella eliminates nearly all need for plant extraction by concentrating the actives within the intact plant cells. Novella developed a production system that combines the use of plant tissue culture propagation and using various stimulation processes aimed at activating metabolic processes in the plant-cell's biomass. The technology is non-GMO and enables the product manufacturing in sterile & controlled systems capable of producing in high commercial scale.